Kanefendt, Friederike <br/><br/>
Determination of soluble vascular endothelial growth factor receptor 3 (sVEGFR-3) in plasma as pharmacodynamic biomarker.  [electronic resource] 

 -  Journal of pharmaceutical and biomedical analysis  Nov 2012 
 - 485-91 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-264X 
<br/><br/><label>Standard No.: </label>10.1016/j.jpba.2012.06.039  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--administration & dosage<br/>Biomarkers, Tumor--blood<br/>Calibration<br/>Colorectal Neoplasms--blood<br/>Enzyme-Linked Immunosorbent Assay--standards<br/>Germany<br/>Humans<br/>Indoles--administration & dosage<br/>Predictive Value of Tests<br/>Prospective Studies<br/>Protein Kinase Inhibitors--administration & dosage<br/>Protein Stability<br/>Pyrroles--administration & dosage<br/>Reference Standards<br/>Reproducibility of Results<br/>Sunitinib<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor Receptor-3--blood